You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中源協和(600645.SH):決定與北京大學第三醫院簽訂科研合作協議
格隆匯 12-07 15:54

格隆匯 12 月 7日丨中源協和(600645.SH)公佈,隨着全球範圍內細胞產業的快速發展,“細胞治療及臨牀轉化”已成為我國“十三五”健康保障發展的重大課題。為滿足日益增長的細胞臨牀應用需求,公司決定與北京大學第三醫院(“北醫三院”)簽訂《科研合作協議》,公司將分期投入科研合作費用5000萬元,在整合雙方優勢的基礎上,開展細胞研發、細胞存儲、細胞應用等全面戰略性合作,實現幹細胞與免疫細胞從規模化儲存到規模化應用,共同推進幹細胞臨牀研究備案,建立京津冀臨牀級細胞存儲與應用示範基地,實現細胞產品臨牀研究、藥物研發、臨牀轉化一體化對接。

次與北醫三院簽訂科研合作協議,是為滿足日益增長的細胞臨牀應用需,通過整合雙方優勢,進一步推動公司細胞產品臨牀研究、藥物研發、臨牀轉以及幹細胞臨牀研究備案,有助於提高公司在細胞研發和應用領域的核心競爭力,符合公司的發展戰略和全體股東的利益,有利於公司的長遠可持續發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account